- Home
- CRGY vs STAA Comparison
CRGY vs STAA Comparison
Compare CRGY & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | STAA |
|---|---|---|
| Founded | 1986 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 1.1B |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CRGY | STAA |
|---|---|---|
| Price | $13.16 | $20.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $14.73 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 5.3M | 803.8K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $3,579,782,000.00 | $239,442,000.00 |
| Revenue This Year | $29.70 | $30.82 |
| Revenue Next Year | N/A | $8.41 |
| P/E Ratio | $99.08 | ★ $73.38 |
| Revenue Growth | ★ 22.14 | N/A |
| 52 Week Low | $7.68 | $15.59 |
| 52 Week High | $15.47 | $35.87 |
Technical Indicators
Market Signals| Indicator | CRGY | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 45.78 | 36.06 |
| Support Level | $11.45 | $19.82 |
| Resistance Level | $14.06 | $20.49 |
| Average True Range (ATR) | 0.46 | 1.05 |
| MACD | -0.24 | -0.25 |
| Stochastic Oscillator | 8.74 | 19.60 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an energy company committed to delivering value for shareholders through disciplined growth, acquisition ideas, and the consistent return of capital. Its long-life, balanced portfolio combines stable cash flows from low-decline production with deep, high-quality development inventory. The company operates in one reportable segment, which is the exploration and production of crude oil, natural gas, and NGLs.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.